NDC 0409-7535-01 - Marcaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-7535
- Requested NDC
- 0409-7535-01
- Package NDCs from labels
- 0409-7535-01, 0409-7535-25
- Manufacturer
- Hospira, Inc. | Pfizer Healthcare India Private Limited
- Effective date
- 2026-10-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Marcaine - Hospira, Inc. | Pfizer Healthcare India Private Limited | Hospira, Inc. | Pfizer Healthcare India Private Limited | 2026-10-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-7535-01 | Marcaine | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 37 | |
| 0409-7535-25 | Marcaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 37 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0409-7535 | MARCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION MARCAINE WITH EPINEPHRINE (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 33 | Current NDC, 2 package rows | 20250529_67578b56-7540-487e-1fba-481255620e78.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-7535-01 | ML - Milliliter | 0409-7535 | 80ad93b1-6a1f-47c7-ab02-5ab897e83ae2 | 1 | 2025-06-13 |
| 0409-7535-25 | ML - Milliliter | 0409-7535 | 86aa74a7-fc3d-4b7c-acb9-30e57c4a9d88 | 1 | 2025-06-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 037ac04d-f8f3-4bb8-993a-ac8f7683ff83 | 2024-01-04 | Warnings, Adverse reactions | 451W47IQ8X |
| Leader Eye Wash | PURIFIED WATER | Cardinal Health | 8d3ad11f-1945-f838-e053-2995a90a7aa5 | 2023-12-23 | Warnings | 059QF0KO0R |
| Sinus HP | ARSENICUM ALBUM, HEPAR SULPHURIS CALCAREUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SEPIA, THUJA OCCIDENTALIS | Energique, Inc. | 3cdddbe5-e3d2-4629-a045-868e18183f1d | 2023-12-19 | Warnings | 451W47IQ8X |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 28488c7b-cf6a-4a03-916f-cc66b3afdc57 | 2023-12-14 | Warnings, Adverse reactions | 451W47IQ8X |
| Altachlore Sodium Chloride Hypertonicity | SODIUM CHLORIDE | Altaire Pharmaceuticals Inc. | dc0d94d8-4475-4956-8ded-bdb9496074e4 | 2023-12-09 | Warnings | 451W47IQ8X |
| Eye Wash | WATER | Jiangxi Zhenmei Biological Technology Co.,Ltd | c68795b8-bf68-0d01-e053-2a95a90abebb | 2023-12-04 | Warnings | 059QF0KO0R |
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | A-S Medication Solutions | 38610ee9-4e70-4a8a-a5c5-6c148cf145f0 | 2023-12-04 | Warnings, Adverse reactions | 30Q7KI53AK |
| terrasil Eczema and Psoriasis Severe Outbreak | GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG | Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions | 4d7128fb-57f1-4d0d-a83a-daef40928ecd | 2023-11-30 | Warnings | 451W47IQ8X |
| terragen HG Formula Maximum Strength | GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG | Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions | e632c831-e25d-4d04-ba72-2327d25713b1 | 2023-11-30 | Warnings | 451W47IQ8X |
| Davimet-M | MULTIVITAMIN | PureTek Corporation | 0b67e8de-d81e-0fda-e063-6394a90ac229 | 2023-11-30 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Femstat C | ECHINACEA (ANGUSTIFOLIA), FUCUS VESICULOSUS, HYDRASTIS CANADENSIS, PHYTOLACCA DECANDRA, KREOSOTUM, NATRUM MURIATICUM, CANDIDA ALBICANS, LYCOPODIUM CLAVATUM, PULSATILLA (PRATENSIS), SEPIA | Energique, Inc. | 420119ca-f2bf-40e3-9e40-00498724c228 | 2023-11-30 | Warnings | 451W47IQ8X |
| Cellular Oxygenator | CACTUS GRANDIFLORUS, ASCORBICUM ACIDUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, THIAMINUM HYDROCHLORICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, RIBOFLAVINUM, MAGNESIA PHOSPHORICA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-LIPOICUM ACIDUM, ANTHRACHINONUM, COENZYME A, NADIDUM, NAJA TRIPUDIANS, UBIDECARENONUM (COQ10) | Nutritional Specialties, Inc. | e5869f25-276f-456a-ab05-2a1899845afb | 2023-11-21 | Warnings | PQ6CK8PD0R |
| Endopar | GLANDULA SUPRARENALIS SUIS, HYPOPHYSIS SUIS, HYPOTHALAMUS SUIS, OOPHORINUM (SUIS), ORCHITINUM (BOVINE), PINEAL GLAND, THYROIDINUM, ARSENICUM ALBUM, BARYTA CARBONICA, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, PULSATILLA (PRATENSIS) | Energique, Inc. | 06375c3e-cc05-4450-9117-1d3dc72636eb | 2023-11-21 | Warnings | 451W47IQ8X |
| Pain Formula | SALIX ALBA, ASCORBICUM ACIDUM, VITAMIN A, VITAMIN E, ACETYLSALICYLICUM ACIDUM | Nutritional Specialties, Inc. | 0cc0d205-83c2-4205-a93c-6a8ba55956d4 | 2023-11-20 | Warnings | PQ6CK8PD0R |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643994f-4e13-4572-e053-2991aa0a5b78 | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 6907bbfe-caa5-2ce4-e053-2991aa0ade8d | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643c518-13b2-658a-e053-2a91aa0ac5ed | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643e30e-1f47-09f1-e053-2991aa0ac2de | 2023-11-14 | QTT17582CB | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8646d7ea-cf5e-607d-e053-2a91aa0aeca1 | 2023-11-14 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 86466121-7217-d053-e053-2a91aa0a8f8a | 2023-11-14 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.